EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
Tóm tắt
Từ khóa
Tài liệu tham khảo
Stenzl, 2011, Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines, Eur Urol, 59, 1009, 10.1016/j.eururo.2011.03.023
Witjes JA, Compérat E, Cowan C, et al. members of the EAU Guidelines Panel on Muscle-invasive and Metastatic Bladder Cancer. Guidelines on muscle-invasive and metastatic bladder cancer. Presented at: EAU Annual Congress 2013; March 15–19, 2013; Milan, Italy.
Ploeg, 2009, The present and future burden of urinary bladder cancer in the world, World J Urol, 27, 289, 10.1007/s00345-009-0383-3
Freedman, 2011, Association between smoking and risk of bladder cancer among men and women, JAMA, 306, 737, 10.1001/jama.2011.1142
Gandini, 2008, Tobacco smoking and cancer: a meta-analysis, Int J Cancer, 122, 155, 10.1002/ijc.23033
Brennan, 2000, Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies, Int J Cancer, 86, 289, 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M
Pashos, 2002, Bladder cancer: epidemiology, diagnosis, and management, Cancer Pract, 10, 311, 10.1046/j.1523-5394.2002.106011.x
Harling, 2010, Bladder cancer among hairdressers: a meta-analysis, Occup Environ Med, 67, 351, 10.1136/oem.2009.050195
Kogevinas, 2003, Occupation and bladder cancer among men in Western Europe, Cancer Causes Control, 14, 907, 10.1023/B:CACO.0000007962.19066.9c
Nieder, 2008, Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study, J Urol, 180, 2005, 10.1016/j.juro.2008.07.038
Zelefsky, 2012, Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer, Int J Radiat Oncol Biol Phys, 83, 953, 10.1016/j.ijrobp.2011.08.034
Vaidya, 2001, De novo muscle invasive bladder cancer: is there a change in trend?, J Urol, 165, 47, 10.1097/00005392-200101000-00012
May, 2012, Gender-dependent cancer-specific survival following radical cystectomy, World J Urol, 30, 707, 10.1007/s00345-011-0773-1
2009, 262
Sauter, 2004, Tumours of the urinary system: non-invasive urothelial neoplasias, 29
Hansel, 2013, A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens, Eur Urol, 63, 321, 10.1016/j.eururo.2012.10.008
Baltaci, 2011, Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology, BJU Int, 107, 547, 10.1111/j.1464-410X.2010.09504.x
Yu, 2006, Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy, J Urol, 176, 493, 10.1016/j.juro.2006.03.065
Tilki, 2010, Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome, Eur Urol, 58, 112, 10.1016/j.eururo.2010.01.015
Gakis, 2011, Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series, BJU Int, 107, 919, 10.1111/j.1464-410X.2010.09548.x
Mitra, 2013, A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer, BJU Int, 111, 240, 10.1111/j.1464-410X.2012.11424.x
Ploeg, 2012, Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomy, Urol Oncol, 30, 247, 10.1016/j.urolonc.2009.12.020
Mungan, 2005, Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder, Eur Urol, 48, 760, 10.1016/j.eururo.2005.05.021
Kassouf, 2008, Prostatic urethral biopsy has limited usefulness in counselling patients regarding final urethral margin status during orthotopic neobladder reconstruction, J Urol, 180, 164, 10.1016/j.juro.2008.03.037
Gakis, 2010, Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery, BJU Int, 105, 468, 10.1111/j.1464-410X.2009.08739.x
Rajesh, 2011, Bladder cancer: evaluation of staging accuracy using dynamic MRI, Clin Radiol, 66, 1140, 10.1016/j.crad.2011.05.019
Yoshida, 2012, Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer, Int J Radiat Oncol Biol Phys, 83, e21, 10.1016/j.ijrobp.2011.11.065
Mertens, 2013, Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle, BJU Int, 112, 729, 10.1111/bju.12109
Babjuk M, Oosterlinck W, Sylvester R, et al., members of the EAU Guidelines Panel on Non-muscle Invasive Bladder Cancer. Guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). Presented at: EAU Annual Congress 2013; March 15–19, 2013; Milan, Italy.
Malmström, 2009, An individual patient data meta-analysis of the longterm outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer, Eur Urol, 56, 247, 10.1016/j.eururo.2009.04.038
Duchek, 2010, Bacillus Calmette-Guérin is superior to a combination of epirubicin and interferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer: a prospective, randomized, Nordic study, Eur Urol, 57, 25, 10.1016/j.eururo.2009.09.038
van den Bosch, 2011, Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review, Eur Urol, 60, 493, 10.1016/j.eururo.2011.05.045
Brake, 2000, Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin, J Urol, 163, 1697, 10.1016/S0022-5347(05)67523-4
Pansadoro, 1995, Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results, J Urol, 154, 2054, 10.1016/S0022-5347(01)66692-8
Stein, 2006, Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure, World J Urol, 24, 296, 10.1007/s00345-006-0061-7
Rosenblatt, 2012, Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer, Eur Urol, 61, 1229, 10.1016/j.eururo.2011.12.010
Nishimura, 2009, The effects of neoadjuvant chemotherapy and chemo-radiation therapy on MRI staging in invasive bladder cancer: comparative study based on the pathological examination of whole layer bladder wall, Int Urol Nephrol, 41, 869, 10.1007/s11255-009-9566-5
Sternberg, 2003, Can patient selection for bladder preservation be based on response to chemotherapy?, Cancer, 97, 1644, 10.1002/cncr.11232
Sherif, 2004, Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies, Eur Urol, 45, 297, 10.1016/j.eururo.2003.09.019
2003, Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis, Lancet, 361, 1927, 10.1016/S0140-6736(03)13580-5
Winquist, 2004, Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis, J Urol, 171, 561, 10.1097/01.ju.0000090967.08622.33
2005, Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data, Eur Urol, 48, 202, 10.1016/j.eururo.2005.04.006
2011, International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial, J Clin Oncol, 29, 2171, 10.1200/JCO.2010.32.3139
Bolenz, 2010, Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival, BJU Int, 106, 1324, 10.1111/j.1464-410X.2010.09417.x
Lughezzani, 2011, A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer, Cancer, 117, 103, 10.1002/cncr.25345
Mayr, 2012, Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder, BJU Int, 110, E222, 10.1111/j.1464-410X.2012.10938.x
Morgan, 2011, Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy, J Urol, 186, 829, 10.1016/j.juro.2011.04.089
Abdollah, 2012, Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study, Ann Surg Oncol, 19, 309, 10.1245/s10434-011-1852-7
Mayr, 2012, Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder, Eur Urol, 62, 662, 10.1016/j.eururo.2012.03.057
Malavaud, 2001, Complications for radical cystectomy impact of the American Society of Anesthesiologists score, Eur Urol, 39, 79, 10.1159/000052416
Chang, 2003, Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage, J Urol, 170, 1085, 10.1097/01.ju.0000086828.26001.ca
Sánchez-Ortiz, 2003, An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma, J Urol, 169, 110, 10.1016/S0022-5347(05)64047-5
Jensen, 2010, Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery, BJU Int, 106, 199, 10.1111/j.1464-410X.2009.09118.x
Zlotta, 2012, Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform?, Eur Urol, 61, 243, 10.1016/j.eururo.2011.11.006
Bruins M, Veskimae E, Hernandez V, et al. Systematic review of role and extent of lymphadenectomy during radical cystectomy for cN0M0 muscle invasive bladder cancer: methods protocol. EAU MIBC Guideline 2013 update. http://www.uroweb.org/gls/refs/Systematic_methodology_Bladder_Cancer_2013_update.pdf.
Karl, 2009, The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer, Eur Urol, 55, 826, 10.1016/j.eururo.2009.01.004
Svatek, 2012, Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer, Curr Urol Rep, 13, 115, 10.1007/s11934-012-0235-3
Figueroa, 1998, Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients, Cancer, 83, 141, 10.1002/(SICI)1097-0142(19980701)83:1<141::AID-CNCR19>3.0.CO;2-X
Hautmann, 2010, Lessons learned from 1,000 neobladders: the 90-day complication rate, J Urol, 184, 990, 10.1016/j.juro.2010.05.037
Kilciler, 2006, Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion, Urol Int, 77, 245, 10.1159/000094817
Pycha, 2008, Comparison of complications in three incontinent urinary diversions, Eur Urol, 54, 825, 10.1016/j.eururo.2008.04.068
Wiesner, 2006, Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs, World J Urol, 24, 315, 10.1007/s00345-006-0078-y
Hautmann, 2011, 25 years of experience with 1,000 neobladders: long-term complications, J Urol, 185, 2207, 10.1016/j.juro.2011.02.006
Hautmann, 2006, Long-term results of standard procedures in urology: the ileal neobladder, World J Urol, 24, 305, 10.1007/s00345-006-0105-z
Porter, 2005, Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature, J Urol, 173, 1318, 10.1097/01.ju.0000149080.82697.65
Eastham, 2009, Do high-volume hospitals and surgeons provide better care in urologic oncology?, Urol Oncol, 27, 417, 10.1016/j.urolonc.2009.01.010
Ok, 2005, Medical and surgical palliative care of patients with urological malignancies, J Urol, 174, 1177, 10.1097/01.ju.0000173077.84274.01
Goel, 1985, Intravesical irrigation with alum for the control of massive bladder hemorrhage, J Urol, 133, 956, 10.1016/S0022-5347(17)49330-X
Huncharek, 1998, Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis, Anticancer Res, 18, 1931
Slack, 1977, Five-year follow-up results of a collaborative study of therapies for carcinoma of the bladder, J Surg Oncol, 9, 393, 10.1002/jso.2930090410
Widmark, 2003, A systematic overview of radiation therapy effects in urinary bladder cancer, Acta Oncol, 42, 567, 10.1080/02841860310014408
Granfors, 2009, Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma, Scand J Urol Nephrol, 43, 293, 10.1080/00365590902854313
Solsona, 2010, Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer, J Urol, 184, 475, 10.1016/j.juro.2010.04.008
Shelley, 2002, Surgery versus radiotherapy for muscle invasive bladder cancer, Cochrane Database Syst Rev, CD002079
Chung, 2007, Long-term outcome of radiation-based conservation therapy for invasive bladder cancer, Urol Oncol, 25, 303, 10.1016/j.urolonc.2006.09.015
Weight, 2009, Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series, Cancer, 115, 792, 10.1002/cncr.24106
Krause, 2011, 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment, Anticancer Res, 31, 985
2005, Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data, Eur Urol, 48, 189, 10.1016/j.eururo.2005.04.005
Bajorin, 1999, Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy, J Clin Oncol, 17, 3173, 10.1200/JCO.1999.17.10.3173
von der Maase, 2005, Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer, J Clin Oncol, 23, 4602, 10.1200/JCO.2005.07.757
Pal, 2010, Impact of age, sex, and comorbidity on cancer therapy and disease progression, J Clin Oncol, 28, 4086, 10.1200/JCO.2009.27.0579
Bamias, 2005, The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy, Ann Oncol, 16, 307, 10.1093/annonc/mdi039
Sternberg, 1989, Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium: efficacy and patterns of response and relapse, Cancer, 64, 2448, 10.1002/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7
von der Maase, 2000, Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study, J Clin Oncol, 18, 3068, 10.1200/JCO.2000.18.17.3068
Sternberg, 2006, Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours, Eur J Cancer, 42, 50, 10.1016/j.ejca.2005.08.032
Bellmunt, 2012, Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987, J Clin Oncol, 30, 1107, 10.1200/JCO.2011.38.6979
Dash, 2006, Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder, Cancer, 107, 506, 10.1002/cncr.22031
De Santis, 2012, Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC Study 30986, J Clin Oncol, 30, 191, 10.1200/JCO.2011.37.3571
Albers, 2002, Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma—prognostic factors for response and improvement of quality of life, Onkologie, 25, 47, 10.1159/000055202
Bellmunt, 2009, Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract, J Clin Oncol, 27, 4454, 10.1200/JCO.2008.20.5534
Siefker-Radtke, 2004, Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience, J Urol, 171, 145, 10.1097/01.ju.0000099823.60465.e6
Coleman, 2001, Metastatic bone disease: clinical features, pathophysiology and treatment strategies, Cancer Treat Rev, 27, 165, 10.1053/ctrv.2000.0210
Henry, 2011, Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma, J Clin Oncol, 29, 1125, 10.1200/JCO.2010.31.3304
Autorino, 2009, Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder, Eur J Surg Oncol, 35, 858, 10.1016/j.ejso.2008.08.002
Stenzl, 2010, Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results, Int Braz J Urol, 36, 537, 10.1590/S1677-55382010000500003
Philip, 2009, Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy—a quality-of-life based comparison, Ann R Coll Surg Engl, 91, 565, 10.1308/003588409X432293
Hedgepeth, 2010, Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions, Urology, 76, 671, 10.1016/j.urology.2010.01.087
Roychowdhury, 2003, Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer, J Clin Oncol, 21, 673, 10.1200/JCO.2003.04.166
Malkowicz, 2007, Muscle-invasive urothelial carcinoma of the bladder, Urology, 69, 3, 10.1016/j.urology.2006.10.040
Mathers, 2008, Is there evidence for a multidisciplinary follow-up after urological cancer? an evaluation of subsequent cancers, World J Urol, 26, 251, 10.1007/s00345-008-0244-5
Ghoneim, 2008, Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later, J Urol, 180, 121, 10.1016/j.juro.2008.03.024